Novavax COVID vaccine OK’d in Europe after months of delays
It’s a boost for Novavax, which has suffered months of delays despite securing some of the largest funding in the early stages of the pandemic.
from Sydney Morning Herald - World https://ift.tt/3shPb18
from Sydney Morning Herald - World https://ift.tt/3shPb18
Comments
Post a Comment